201 related articles for article (PubMed ID: 22451118)
1. Impedance pH confirms the relationship between GERD and BMI.
Hajar N; Castell DO; Ghomrawi H; Rackett R; Hila A
Dig Dis Sci; 2012 Jul; 57(7):1875-9. PubMed ID: 22451118
[TBL] [Abstract][Full Text] [Related]
2. Twice-daily proton pump inhibitor therapy does not decrease the frequency of reflux episodes during nocturnal recumbency in patients with refractory GERD: analysis of 200 patients using multichannel intraluminal impedance-pH testing.
Clayton SB; Rife CC; Singh ER; Kalbfleisch JH; Castell DO
Dis Esophagus; 2012; 25(8):682-6. PubMed ID: 22292567
[TBL] [Abstract][Full Text] [Related]
3. Reflux characteristics of 113 GERD patients with abnormal 24-h multichannel intraluminal impedance-pH tests.
Nian YY; Feng C; Jing FC; Wang XQ; Zhang J
J Zhejiang Univ Sci B; 2015 Sep; 16(9):805-10. PubMed ID: 26365123
[TBL] [Abstract][Full Text] [Related]
4. Refractory GERD: increased body mass index is associated with persisting acid exposure but not hypersensitive esophagus or functional heartburn.
Viazis N; Karamanolis GP; Anastasiou J; Keyoglou A; Vlachogiannakos J; Ladas SD; Karamanolis DG
Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1450-5. PubMed ID: 24047861
[TBL] [Abstract][Full Text] [Related]
5. Can Impedance-pH Testing on Medications Reliably Identify Patients with GERD as Defined by Pathologic Esophageal Acid Exposure off Medications?
Ward MA; Dunst CM; Glasgow ME; Teitelbaum EN; Abdelmoaty WF; Reavis KM; Swanstrӧm LL; DeMeester SR
J Gastrointest Surg; 2019 Jul; 23(7):1301-1308. PubMed ID: 30859425
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
[TBL] [Abstract][Full Text] [Related]
7. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?
de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S
World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200
[TBL] [Abstract][Full Text] [Related]
8. Persistent Postprandial Regurgitation vs Rumination in Patients With Refractory Gastroesophageal Reflux Disease Symptoms: Identification of a Distinct Rumination Pattern Using Ambulatory Impedance-pH Monitoring.
Nakagawa K; Sawada A; Hoshikawa Y; Nikaki K; Sonmez S; Woodland P; Yazaki E; Sifrim D
Am J Gastroenterol; 2019 Aug; 114(8):1248-1255. PubMed ID: 31246694
[TBL] [Abstract][Full Text] [Related]
9. Positive predictors for gastroesophageal reflux disease and the therapeutic response to proton-pump inhibitors.
Becker V; Grotz S; Schlag C; Nennstiel S; Beitz A; Haller B; Schmid RM; Meining A; Bajbouj M
World J Gastroenterol; 2014 Apr; 20(14):4017-24. PubMed ID: 24744591
[TBL] [Abstract][Full Text] [Related]
10. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring.
Mainie I; Tutuian R; Shay S; Vela M; Zhang X; Sifrim D; Castell DO
Gut; 2006 Oct; 55(10):1398-402. PubMed ID: 16556669
[TBL] [Abstract][Full Text] [Related]
11. Laryngopharyngeal Reflux Disease is More Severe in Obese Patients: A Prospective Multicenter Study.
Lechien JR; Bobin F; Muls V; Saussez S; Hans S
Laryngoscope; 2021 Nov; 131(11):E2742-E2748. PubMed ID: 34086292
[TBL] [Abstract][Full Text] [Related]
12. Combined esophageal multichannel intraluminal impedance and pH monitoring (MII -pH) in the diagnostics and treatment of gastroesophageal reflux disease and its complications.
Masiak W; Wallner G; Wallner J; Pedowski T; Solecki M
Pol Przegl Chir; 2011 Sep; 83(9):488-96. PubMed ID: 22166737
[TBL] [Abstract][Full Text] [Related]
13. Multichannel intraluminal impedance in the evaluation of patients with persistent globus on proton pump inhibitor therapy.
Anandasabapathy S; Jaffin BW
Ann Otol Rhinol Laryngol; 2006 Aug; 115(8):563-70. PubMed ID: 16944654
[TBL] [Abstract][Full Text] [Related]
14. Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough.
Ribolsi M; Savarino E; De Bortoli N; Balestrieri P; Furnari M; Martinucci I; Casale M; Greco F; Salvinelli F; Savarino V; Marchi S; Cicala M
Aliment Pharmacol Ther; 2014 Oct; 40(8):966-73. PubMed ID: 25109844
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Gastroesophageal Reflux by Combined Multichannel Intraluminal Impedance and pH Monitoring and Esophageal Motility Patterns in Children with Esophageal Atresia.
Tong S; Mallitt KA; Krishnan U
Eur J Pediatr Surg; 2016 Aug; 26(4):322-31. PubMed ID: 26445355
[TBL] [Abstract][Full Text] [Related]
16. Prospective study examining the impact of multichannel intraluminal impedance on antireflux surgery.
Gruebel C; Linke G; Tutuian R; Hebbard G; Zerz A; Meyenberger C; Borovicka J
Surg Endosc; 2008 May; 22(5):1241-7. PubMed ID: 17943361
[TBL] [Abstract][Full Text] [Related]
17. 24-h pH-metry and multichannel intraluminal impedance monitoring in obese patients with and without gastroesophageal reflux disease symptoms.
Ricci G; Amella C; Forti E; Rossi A; Bersani G; Dari S; Pasini V; Maimone A; Alvisi V
Obes Surg; 2011 Jan; 21(1):48-53. PubMed ID: 20835898
[TBL] [Abstract][Full Text] [Related]
18. Tailored therapy for the refractory GERD patients by combined multichannel intraluminal impedance-pH monitoring.
Xiao Y; Liang M; Peng S; Zhang N; Chen M
J Gastroenterol Hepatol; 2016 Feb; 31(2):350-4. PubMed ID: 26202002
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and Anti-Reflux Therapy for GERD with Respiratory Symptoms: A Study Using Multichannel Intraluminal Impedance-pH Monitoring.
Zhang C; Wu J; Hu Z; Yan C; Gao X; Liang W; Liu D; Li F; Wang Z
PLoS One; 2016; 11(8):e0160139. PubMed ID: 27532103
[TBL] [Abstract][Full Text] [Related]
20. Increasing body weight enhances prevalence and proximal extent of reflux in GERD patients 'on' and 'off' PPI therapy.
Blondeau K; Boecxstaens V; Van Oudenhove L; Farré R; Boeckxstaens G; Tack J
Neurogastroenterol Motil; 2011 Aug; 23(8):724-e327. PubMed ID: 21535319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
